Current gold-standard approaches for obstructive sleep apnea (OSA) detection and diagnosis are intrusive, have logistical and financial constraints and can affect the patient’s sleep quality. Type-4 devices have been increasingly used in the setting of resource limitations.
The authors aimed to investigate the correlation (Kappa coefficient) between flow based apnea-hypopnea index (AHIflow50%) and oxygen desaturation index 3% (ODI3%) when concurrently measured using a two-channel ApnealinkTM portable sleep study device in a sample of patients from the general population. They sought to determine if both indices can be used interchangeably.
296 out of an initial 772 patients that had both airflow and oxygen saturation recordings of at least 4 hours were included for analysis. The mean age was 53 years, mean body mass index (BMI) of 29 kg/m2, with 48% being male. Results yielded a median AHIflow50% of 5 (interquartile range 2,10) and median ODI3% of 9 (interquartile range 4,15). The authors found that the AHIflow50% based on airflow alone tended to underestimate obstructive sleep apnea compared to ODI3%. The concordance between AHIflow50% and ODI3% for the diagnosis of OSA and severity classification was 0.32 (moderately discordant), with variations when gender and BMI subgroups were analyzed (worse for increasing BMI and worse for females). The authors suggested caution when using ODI3% as the measure of choice for Type-4 portable sleep studies until further evidence emerges.”
This retrospective review of all consecutive shoulder arthroscopy procedures performed during a 10 year period used a 2:1 control-case matching technique and univariate and multivariate analysis to identify variables associated with admission. Of the 5,598 arthroscopic procedures, 4.2% required admission. The most common reason for admission was respiratory monitoring, OSA increased the odds (OR 1.90) for admission after shoulder surgery. Increasing body mass index, increased age, COPD, diabetes and increased operative times were risk factors for admission. The absence of general anesthesia reduced the risk of admission.
This systematic review and meta-analysis included 12 observational studies. The incidence of postoperative opioid-induced respiratory depression (OIRD) was 5.0 cases per 1000 anesthetics. Eight-five percent of OIRD occurred within the first 24 hours after surgery. Risk factors for OIRD included pre-existing cardiac disease, pulmonary disease, and obstructive sleep apnea. The morphine equivalent daily dose of the postoperative opioids was higher in the OIRD than the control groups.
In this prospective study, 39 obese patients (BMI ≥ 30) with moderate to severe OSA were enrolled. All patients underwent polysomnography, had an arterial blood gas and completed neurocognitive tests before treatment of OSA. Fifteen patients were found to be hypercapneic and considered to have obesity hypoventilation syndrome. These patients had deficits in logical memory and attention and increased reaction times when compared to non-hypercapneic patients with OSA.
The Society of Anesthesia and Sleep Medicine Guideline on Intraoperative Management of Adult Patients With Obstructive Sleep Apnea (OSA) presents recommendations based on current scientific evidence. This guideline addresses questions regarding the intraoperative care of patients with OSA, including airway management, anesthetic drug and agent effects, and choice of anesthesia type. A systematic literature search was performed to capture the current body of evidence as it relates to the intraoperative anesthetic care of patients with OSA. Based on the groundwork of this comprehensive literature review and a consensus process among the guideline member, recommendations reflect the current state of knowledge, the quality of the body of evidence and its interpretation by subject-matter experts. Deviations in practice from the guideline may be justifiable and should not be interpreted as a basis for claims of negligence.
Neuromuscular blocking drugs (NMBD) achieve intraoperative muscle relaxation to facilitate intubation and surgical procedures. Incomplete reversal of NMBD can lead to adverse postoperative events which is of particular concern in patients with obstructive sleep apnea (OSA). This systematic review aimed to determine whether: 1) OSA patients are at higher risk of postoperative complications from the use of NMBD compared to patients without OSA, and 2) whether the choice of NMBD reversal agent would affect the risk of postoperative complications in patients with OSA. The systematic literature search revealed five eligible studies out of 4123 (2 RCTs and 3 observational studies), while the level of evidence was deemed as low to moderate. Overall, OSA patients with intraoperative NMBD use may be at higher risk for postoperative hypoxemia, respiratory failure and residual neuromuscular blockade when compared to non-OSA patients. There is some, albeit very limited evidence suggesting that NMBD reversal with sugammadex may be associated with less PPCs than neostigmine in OSA. More high-quality studies are needed.
The intrinsic nature of opioids to suppress respiratory function is of particular concern among patients with obstructive sleep apnea (OSA). The establishment of OSA as a perioperative risk factor has raised the question of whether affected patients are at higher risk for opioid-induced respiratory depression (OIRD). This systematic review aimed to summarize current evidence with respect to perioperative OIRD, changes in sleep-disordered breathing, and alterations in pain and opioid sensitivity in patients with OSA. Overall, high-quality evidence on the comparative impact of acute opioid analgesia in OSA versus non-OSA patients is lacking. The current body of evidence is burdened by significant limitations including risk of bias and large heterogeneity among studies with regard to OSA severity, perioperative settings, outcome definitions, and the presence or absence of various perioperative drivers. Nevertheless, there is some consistency among studies with regard to a detrimental effect of opioids in the presence of OSA. With regard to OIRD, the initial 24 hours after opioid administration appear to be most critical. OSA-related changes in pain perception and opioid sensitivity may also predispose patients to higher risk for OIRD without overdosing. While high-quality evidence is needed, retrospective analyses indicate that critical, life-threatening OIRD may be preventable with a more cautious approach to opioid use and adequate monitoring.
Given the implications of obstructive sleep apnea (OSA), the minimization of opioids in the perioperative setting is recommended in patients with known or suspected OSA. This retrospective analysis investigated opioid prescribing patterns among patients undergoing surgery from 1 November 2016 to 30 April 2017 at a single academic institution. Patients with known or suspected OSA by STOP-Bang were compared to those without OSA for the amount of postoperative discharge opioid medication using multivariable linear regression. Adjusted analysis showed no significant difference in the amount and rates of opioids prescribed upon discharge between OSA and non-OSA surgical patients, despite guidelines recommending opioid sparing. These findings indicate a need to implement different strategies to reduce opioids to patients with OSA.
Preoperative gabapentinoid (gabapentin and pregabalin) administration has been associated with respiratory depression during anaesthesia recovery. This study assessed associations between chronic (home) use and perioperative (preoperative and postoperative) use of gabapentinoids, and risk for severe over-sedation or respiratory depression as inferred from the use of naloxone. Single center retrospective analysis of 128 patients who received general anaesthesia and required naloxone administration within 48 h postoperatively. Patients were 2:1 matched on age, sex, and type of procedure. Multivariable analysis detected significant interactions between chronic and postoperative use of gabapentinoids, where continuation of chronic gabapentinoid medications into the postoperative period was associated with an increased rate of naloxone administration. Obstructive sleep apnoea and preoperative disability were also associated with an increased risk for postoperative naloxone administration. Continuation of chronic gabapentinoid medications into the postoperative period as well as OSA are associated with the increased use of naloxone to reverse over-sedation or respiratory depression.
Obstructive sleep apnea (OSA) is well established as a driver of postoperative complications. However, despite the high prevalence of OSA, most patients remain undetected in the perioperative setting, which highlights the need for simple screening tools. This prospective observational multicenter study aimed to investigate whether STOP-Bang and oxygen desaturation index can identify subjects with OSA. Analysis included 449 adult patients referred to a sleep clinic for OSA evaluation with ambulatory polysomnography, including pulse oximetry and the STOP-Bang questionnaire in 4 Swedish centers. The STOP-Bang score is the sum of 8 positive answers to Snoring, Tiredness, Observed apnea, high blood Pressure, Body mass index >35 kg/m, Age >50 years, Neck circumference >40 cm, and male Gender.
Overall, data showed that the STOP-Bang tool and pulse oximetry can be used to screen for OSA. A STOP-Bang score of <2 almost excludes moderate and severe OSA, whereas nearly all the patients with a STOP-Bang score ≥6 have OSA. The authors suggested the addition of nightly pulse oximetry in patients with a STOP-Bang score of 2-5 to enable OSA screening.